Citations Report

Clinical Investigation : Citations & Metrics Report

Articles published in Clinical Investigation have been cited by esteemed scholars and scientists all around the world.

Clinical Investigation has got h-index 28, which means every article in Clinical Investigation has got 28 average citations.

Following are the list of articles that have cited the articles published in Clinical Investigation.

• Barrios V, Escobar C (2015) Edoxaban in the prevention and treatment of thromboembolic complications from a clinical point of view. Expert review of cardiovascular therapy 3:811-824. View at Publisher | View at Google Scholar | View at Indexing
• Shantsila E, Lip GY (2016) Non-Vitamin K Antagonist Oral Anticoagulants. Springer International Publishing. View at Publisher | View at Google Scholar | View at Indexing
• 张倩, 陈岑, 杨丰庆, å¤Âä¹‹å®Â. 激动剂诱导血å°Âæ¿æ´»åŒ–机制及抗血å°Âæ¿è¯ç‰©ç ”究进展. 中国药科大学学报. 2014;45(6):632-48. View at Publisher | View at Google Scholar | View at Indexing

• Catenacci DV. Next-generation clinical trials: novel strategies to address the challenge of tumor molecular heterogeneity. Molecular oncology. 2015 May 31;9(5):967-96.

  View at Publisher | View at Google Scholar

• Tajik P, Zwinderman AH, Mol BW, Bossuyt PM. Trial designs for personalizing cancer care: a systematic review and classification. Clinical Cancer Research. 2013 Sep 1;19(17):4578-88.

  View at Publisher | View at Google Scholar

• Myers MB (2016) Targeted therapies with companion diagnostics in the management of breast cancer: current perspectives.Pharmacogenomics and personalized medicine 9 :7.

  View at Publisher | View at Google Scholar

• Nelson EL (2016) HER2/neu: An Increasingly Important Therapeutic Target: Part 2 Distribution of HER2/neu Overexpression and Gene Amplification by Organ, Tumor Site and Histology. Clinical Investigation.

  View at Publisher | View at Google Scholar

• Taverna G, Giusti G, Seveso M, Hurle R, Colombo P, Stifter S, Grizzi F. Mast cells as a potential prognostic marker in prostate cancer. Disease markers. 2013 Nov 11;35(6):711-20.

  View at Publisher | View at Google Scholar

• Nelson EL (2014) HER2/neu: An increasingly important therapeutic target: Part 3. Clinical Applications & Investigations.

  View at Publisher | View at Google Scholar

• Nelson EL (2014) Nelson E An increasingly important therapeutic target: Part 2 Distribution of HER2/neu Overexpression and Gene Amplification by Organ, Tumor Site and Histology.Clinical Investigation 4: 1-24.

  View at Publisher | View at Google Scholar

• Sigdel TK, Gao X, Sarwal MM. Protein and peptide biomarkers in organ transplantation. Biomarkers. 2012 Jun 26;6(3):259-71.

  View at Publisher | View at Google Scholar

• Ondra T, Dmitrienko A, Friede T, Graf A, Miller F, Stallard N, Posch M. Methods for identification and confirmation of targeted subgroups in clinical trials: a systematic review. Journal of biopharmaceutical statistics. 2016 Jan 2;26(1):99-119.

  View at Publisher | View at Google Scholar

• Egan KJ, Vesterinen HM, Mccann SK, Sena ES, Macleod MR (2015) The development of an online database for interventions tested in transgenic mouse models of Alzheimer's disease. Evidence-based Preclinical Medicine 2: 20-26.

  View at Publisher | View at Google Scholar
• Langley GR, Adcock IM, Busquet F, Crofton KM, Csernok E, et al. (2016) Towards a 21st-century roadmap for biomedical research and drug discovery: consensus report and recommendations. Drug Discovery Today. View at Publisher | View at Google Scholar | View at Indexing

• Mandrekar SJ, An MW, Sargent DJ. A review of phase II trial designs for initial marker validation. Contemporary clinical trials. 2013 Nov 30;36(2):597-604.

  View at Publisher | View at Google Scholar

• Bitting RL, Armstrong AJ. Potential predictive biomarkers for individualizing treatment fo

  View at Publisher | View at Google Scholar

• Antoniou M, Jorgensen AL, Kolamunnage-Dona R. Biomarker-guided adaptive trial designs in phase II and phase III: a methodological review. PloS one. 2016 Feb 24;11(2):e0149803.

  View at Publisher | View at Google Scholar

• Gu X, Chen N, Wei C, Liu S, Papadimitrakopoulou VA, Herbst RS, Lee JJ. Bayesian two-stage biomarker-based adaptive design for targeted therapy development. Statistics in biosciences. 2016 Jun 1;8(1):99-128.

  View at Publisher | View at Google Scholar

• Kümler I, Stenvang J, Moreira J, Brünner N, Nielsen DL. Drug transporters in breast cancer: response to anthracyclines and taxanes. Expert review of anticancer therapy. 2015 Sep 2;15(9):1075-92.

  View at Publisher | View at Google Scholar

• Leong TY. Toward patient-centered, personalized and personal decision support and knowledge management: a survey. IMIA Yearbook. 2012:104-12.

  View at Publisher | View at Google Scholar

• Ondra T, Jobjörnsson S, Beckman RA, Burman CF, König F, Stallard N, Posch M. Optimizing trial designs for targeted therapies. PloS one. 2016 Sep 29;11(9):e0163726.

  View at Publisher | View at Google Scholar

• Antoniou M, Kolamunnage-Dona R, Jorgensen AL. Biomarker-Guided Non-Adaptive Trial Designs in Phase II and Phase III: A Methodological Review. Journal of Personalized Medicine. 2017 Jan 25;7(1):1.

  View at Publisher | View at Google Scholar

• Martinalbo Flores JA. Desarrrollo y acceso al mercado de medicamentos oncológicos personalizados.

  View at Publisher | View at Google Scholar
• Nelson, EL. HER2/neu: An increasingly important therapeutic target: Part 3 Clinical Applications & Investigations. 2014. View at Publisher | View at Google Scholar | View at Indexing
• Black AT (2015) Dermatological Drugs, Topical Agents, and Cosmetics. Side Effects of Drugs Annual 37: 175-184. View at Publisher | View at Google Scholar | View at Indexing
• SALIM MZ (2016) L’APPORT DE L’IMMUNOHISTOCHIMIE DANS LE MYCOSIS FONGOÏDE. View at Publisher | View at Google Scholar | View at Indexing
• Lopez, Ana Maria. "Telemedicine and clinical trials." Oncology Clinical Trials: Successful Design, Conduct, and Analysis 8 (2018): 441. View at Publisher | View at Google Scholar | View at Indexing

• DesGroseillers L, Lavigne G (2014) PUBLICATIONS DES MEMBRES. Learning 94: 233-259.

  View at Publisher | View at Google Scholar
• Ala S, Enayatifard R, Alvandipour M, Qobadighadikolaei R (2016) Comparison of captopril (0.5%) cream with diltiazem (2%) cream for chronic anal fissure: a prospective randomized doubleâ€Âblind twoâ€Âcentre clinical trial. Colorectal Disease 18:510-516. View at Publisher | View at Google Scholar | View at Indexing

• Wurdinger T, Deumelandt K, van der Vliet HJ, Wesseling P, de Gruijl TD. Mechanisms of intimate and long-distance cross-talk between glioma and myeloid cells: how to break a vicious cycle. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer. 2014 Dec 31;1846(2):560-75.

  View at Publisher | View at Google Scholar
• Whelan J, Zhao Y, Huang EC, MacDonald A, Donohoe D (2016) Zyfl amend and Prostate Cancer Therapy. InComplementary and Alternative Medicines in Prostate Cancer 197-220. View at Publisher | View at Google Scholar | View at Indexing
• Bushman WA, Jerde TJ (2016) The role of prostate inflammation and fibrosis in lower urinary tract symptoms. American Journal of Physiology-Renal Physiology 311 :817-821. View at Publisher | View at Google Scholar | View at Indexing

• Zhang J, Wu H, Li P, Zhao Y, Liu M, Tang H. NF-κB-modulated miR-130a targets TNF-α in cervical cancer cells. Journal of translational medicine. 2014 Jun 1;12(1):155.

  View at Publisher | View at Google Scholar
• Shirani-Boroujeni M, Heidari-Soureshjani S, Hafshejani ZK (2016) Impact of oral capsule of Peganum harmala on alleviating urinary symptoms in men with benign prostatic hyperplasia; a randomized clinical trial. Journal of Renal Injury Prevention 6:127-131. View at Publisher | View at Google Scholar | View at Indexing

• Yang O, Jianhua H, Lin S. Regulatory effects of miRNA on gastric cancer cells. Oncology letters. 2014 Aug 1;8(2):651-6.

  View at Publisher | View at Google Scholar
• Ju JY, Chung KS, Cheon SY, An HJ (2016) Musulju improves benign prostatic hyperplasia by regulating inflammatory and apoptotic proteins. Molecular Medicine Reports 14: 4692-4698. View at Publisher | View at Google Scholar | View at Indexing
• Li J, Dai L, Lei N, Xing M, Li P, (2016) Evaluation and characterization of anti-RalA autoantibody as a potential serum biomarker in human prostate cancer. Oncotarget 7:43546-43556 View at Publisher | View at Google Scholar | View at Indexing

• 韩蓓, 石星, 陆子鹏, 顾玉青, 高文涛. 自发性 1 åž‹ç³–å°¿ç—… NOD 小鼠胰腺微小 RNA 表达谱分析. 中华糖尿病杂志. 2013;5(7):398-402.

  View at Publisher | View at Google Scholar
• Chang AB, O'Grady KA (2014) Clinical trials in pediatrics. Clinical Investigation 4:981-983. View at Publisher | View at Google Scholar | View at Indexing

• Carter A, Humphreys L, Snowdon N, Sharrack B, Daley A, Petty J, Woodroofe N, Saxton J. Participant recruitment into a randomised controlled trial of exercise therapy for people with multiple sclerosis. Trials. 2015 Oct 15;16(1):468.

  View at Publisher | View at Google Scholar

• Chang AB, O'Grady KA (2014) Clinical trials in pediatrics. Clinical Investigation 4:981-983.

  View at Publisher | View at Google Scholar

• Beran RG, Stepanova D, Beran ME. Justification for conducting neurological clinical trials as part of patient care within private practice. International journal of clinical practice. 2016 May 1;70(5):365-71.

  View at Publisher | View at Google Scholar

• Chang AB, O'Grady KA (2014) Clinical trials in pediatrics. Clinical Investigation 4:981-983.

  View at Publisher | View at Google Scholar

• Chang AB, O'Grady KA (2014) Clinical trials in pediatrics. Clinical Investigation 4:981-983.

  View at Publisher | View at Google Scholar
• Chang AB, O'Grady KA (2014) Clinical trials in pediatrics. Clinical Investigation 4:981-983. View at Publisher | View at Google Scholar | View at Indexing
• Tibes, Raoul, et al. "Current outlook on molecular pathogenesis and treatment of myeloproliferative neoplasms." Molecular diagnosis & therapy 16.5 (2012): 269-283. View at Publisher | View at Google Scholar | View at Indexing
• Chang AB, O'Grady KA (2014) Clinical trials in pediatrics. Clinical Investigation 4:981-983. View at Publisher | View at Google Scholar | View at Indexing
• Chang AB, O'Grady KA (2014) Clinical trials in pediatrics. Clinical Investigation 4:981-983. View at Publisher | View at Google Scholar | View at Indexing

• Boyce BF, Rosenberg E, de Papp AE, Duong LT. The osteoclast, bone remodelling and treatment of metabolic bone disease. European journal of clinical investigation. 2012 Dec 1;42(12):1332-41.

  View at Publisher | View at Google Scholar
• Chang AB, O'Grady KA (2014) Clinical trials in pediatrics. Clinical Investigation 4:981-983. View at Publisher | View at Google Scholar | View at Indexing